Abstract
Background
Anastomotic leak (AL) is the most feared complication in colorectal surgery. Indocyanine green (ICG) fluorescence angiography allows for real-time intraoperative evaluation of bowel perfusion. This study aimed to assess the impact of ICG on perioperative outcomes in patients treated with transanal total mesorectal excision (TaTME) for rectal cancer.
Methods
Comparative study based on a retrospective analysis of prospectively collected data, to validate the use of ICG assessment (ICGA) during TaTME (November/2011–June/2018). The primary outcome was the clinical AL rate. The secondary outcomes included modification of proximal colonic transection, anastomotic redo, additional surgical maneuvers and surgical morbidity.
Results
Two hundred and eighty-four patients were included, 204 (71.8%) in non-ICG group and 80 (28.2%) in ICG group. No significant differences were found in patient and tumor features. Mean anastomotic height was 4.85 cm vs. 5.04 cm (p = 0.500), diverting stoma was constructed in 205 patients (72.1% vs. 72.5%; p = 0.941). Fluorescence angiography modified the surgical plan in 23 patients (28.7%). AL was diagnosed in 23 patients (11.3%) in the non-ICG group and in two patients (2.5%) in the ICG group (p = 0.020). Postoperative intraabdominal collection was diagnosed in 19 patients (7.4% vs. 5.1%; p = 0.490), and reintervention was needed in 24 patients (10.8% vs. 7.6%; p = 0.420). Median length of hospital stay was 6.0 (IQR 5.0–9) vs. 4.0 (IQR 3.0–8.5) (p = 0.005). ICGA was found as independent protective factor for AL in the multivariate analysis of the whole cohort (n = 284) (OR 0.142; 95% CI 0.032–0.633; p = 0.010).
Conclusion
ICG fluorescence angiography modified the proximal colonic transection in more than one-quarter of patients, leading to a significant decrease of AL rate.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Anastomotic leak (AL) is the most feared complication in colorectal surgery, occurring in 7–11% of patients following restorative low anterior resection [1,2,3,4,5,6,7,8]. This complication significantly increases morbidity and mortality, leads to reoperations and radiological interventions, and has a direct impact on healthcare costs. Moreover, the risk of a permanent stoma is also increased. Besides, several studies have reported worse oncologic outcome in terms of increased local recurrence, although this remains a controversial issue [9, 10]. The most critical causes of AL are anastomotic tension, mechanical failure, and compromised perfusion. Cardiovascular disease, diabetes, smoking habit, perioperative blood transfusion and previous treatment with chemoradiotherapy are some of the causes that contribute to impaired microperfusion [5, 6, 11].
The use of indocyanine green (ICG) allows for intraoperative evaluation of bowel perfusion and is considered as a promising tool to reduce the AL rate [12, 13]. ICG is administered intravenously, and perfusion can be evaluated via fluorescence angiography. Based on the line of demarcation, a site of bowel transection is decided. Several research groups have reported that this technique may change the proximal resection margin in up to 8% of patients with rectal anastomosis, with an average AL rate of 1.4–4% [6, 14].
The enhanced recovery provided by minimal access techniques has been a solid reason for the implementation of laparoscopy in rectal cancer surgery. However, the laparoscopic approach to the total mesorectal excision (TME) is still challenging to perform, especially in difficult cases with narrow pelvises and low tumors. Robotic TME seems to overcome this issue, although there is a global debate about its cost-effectiveness. The development of the transanal total mesorectal excision (TaTME) represents the last step forward, whose feasibility and quality has been well evaluated by different studies and international registries [15,16,17,18,19,20,21]. This study aimed to assess the impact of ICG on perioperative outcomes in patients treated with TaTME for rectal cancer. We hypothesized that the use of ICG fluorescence angiography would reduce the AL rate.
Methods
This was a single-center comparative study based on a retrospective analysis of prospectively collected data. The study population comprised patients with rectal cancer treated with TaTME between November 2011 and June 2018. Cohorts were based on the date when ICG assessment (ICGA) was incorporated to our routine practice: from November 2011 to February 2016 for the non-ICGA group, and from March 2016 to June 2018 for the ICGA group. The primary outcome was the early clinical AL rate (during the first 30 days after index surgery). The secondary outcomes included the modification of the proximal colonic transection rate, the need for an anastomotic redo, additional surgical maneuvers, and surgical morbidity.
Inclusion criteria were adult patients diagnosed with primary rectal cancer, undergoing elective curative TaTME with planned colorectal/coloanal anastomosis. Patients treated with abdominoperineal resection or Hartmann, pregnant or breastfeeding women, and those with non-adenocarcinoma tumors were excluded. Patients with known allergy to ICG or iodine and patients treated with iodine dyes or drugs known to interact with ICG (anticonvulsants, drugs containing bisulfite, methadone, nitrofurantoin) were not eligible. Before surgery, patients signed informed consent to participate in the study before surgery. The Institutional Review Board of the Hospital Clinic of Barcelona approved the feasibility of the trial.
Gathered data included demographic variables (age, sex, Body Mass Index (BMI), American Society of Anesthesiologists classification (ASA), tobacco or alcohol consumption, complete medical history, nutritional status), preoperative blood test, tumor characteristics (distance from the anal verge, TNM stage, neoadjuvant chemoradiotherapy), safety profile of ICG (allergic reactions, complications), surgical characteristics (level of ligation of inferior mesenteric artery (IMA), splenic flexure mobilization, level and type of anastomosis, extraction site, surgical time, stoma), 30-day morbidity, reinterventions and hospital stay. Specifically, for the ICG group, we recorded the modification of the proximal colonic transection line, which was defined as a variation in the original transection line due to deficient perfusion observed with fluorescence ICG angiography. The need for additional surgical maneuvers was also recorded, such as splenic flexure mobilization or influence in the decision of performing a protective stoma were also recorded.
Our group has described the TaTME technique in previous studies, and we refer to those manuscripts for an extensive explanation [22]. Rectal cancer was defined as a tumor with a distal margin within 15 cm of the rectum through endoscopic and/or radiological evaluation. IMA ligation proximal to the left colic vessels was labeled "high," and ligation of rectalis superior with preservation of arteria colica sinistra as "low." The decision to protect the anastomosis with a diverting stoma was at the discretion of the surgeon. Clinical AL was defined as a confirmed defect of the intestinal wall at the level of the anastomosis, which leads to intra and extraluminal communication, as proven by the following: anastomotic defect noted on digital rectal examination, or radiologic evidence of extravasation of rectal contrast that has an impact on patient management [23].
ICG assessment
The PINPOINT® Endoscopic Fluorescence Imaging System from Novadaq Technologies Inc. used at our center allows the surgeon to evaluate perfusion with visible high-definition endoscopic fluorescence (VIS) and near-infrared spectroscopy (NIR) images in real time. The PINPOINT® system includes an optimized laparoscope and camera head for VIS and NIR illumination and visualization, generating simultaneous standard high-definition white light images and real-time VIS and NIR high-definition fluorescence images. Real-time NIR fluorescence video images can be viewed in two ways: PINPOINT® image, in which the NIR fluorescence is superimposed on pseudocolor (green) on a white light image; and the SPY image, in which a black and white NIR fluorescence image is displayed. PINPOINT® is designed to connect to a high-definition monitor, and all components can be mounted in a laparoscopic tower.
The PINPOINT® was used to assess the intestinal perfusion in two critical steps of the operation: just before the proximal colonic transection, and after performing the anastomosis, evaluating the mucosa by transanal visualization. For the initial evaluation, the planned transection colonic line was marked by the surgeon, usually with electrocautery, under white light before injecting ICG. This was made after bowel mobilization, transection of the rectum, section of the inferior mesenteric vessels, mobilization of the splenic flexure (if considered necessary) and the section of the mesocolon, once the specimen was externalized transabdominally or transanally and before the creation of the anastomosis. Following the manufacturer’s instructions, a bolus of ICG of 2.5 mg/ml was administered intravenously by the anesthesiology team. The fluorescence intensity in the proximal colon was subjectively evaluated as "fluorescent" or "non-fluorescent." Colonic perfusion was assessed using the PINPOINT® system, and the line between perfused and non-perfused tissue was marked and compared with the planned initial transection point.
The anastomosis was then constructed after which an endoluminal evaluation of the anastomotic perfusion was performed with a second ICG bolus of 2.5 mg/ml. Through the transanal device placed again in the anus, the PINPOINT® endoscope was introduced. A third dose of ICG was allowed (for example, after an additional surgical maneuver such as mobilization of the splenic flexure) if the surgeon considered it necessary.
Statistical analysis
Parametric data were reported as means with standard deviation (SD), and non-parametric data were reported as medians with corresponding interquartile range (IQR). The qualitative variables were expressed as relative and absolute frequencies. To identify differences between the study groups, Student t test or Mann–Whitney U test were used in the continuous variables. Chi-squared test and Fisher’s exact test were used in the qualitative variables. A p value lower or equal to 0.05 was considered to represent statistical significance for all comparisons. Univariate logistic regression was applied, after categorizing continuous variables into clinically relevant groups. Those variables with p value lower or equal to 0.100 were included in the multivariate logistic regression analysis. All statistical analyses were performed in the Statistical Package for Social Sciences (SPSS) of IBM Statistics, version 24 (IBM Corp., Armonk, NY, USA).
Results
During the study period, a total of 284 patients met the inclusion criteria and were analyzed (204 in the non-ICGA group and 80 in the ICGA group). No significant differences were observed in baseline characteristics, so no statistical measures to avoid allocation bias were required. Patient and tumor features are detailed in Table 1.
Operative details are noted in Table 2. All patients were operated by TaTME assisted by laparoscopy. The specimen exteriorization was performed transanally in 116 (56.9%) patients in the non-ICGA group vs. 19 (24.1%) in the ICGA group (p < 0.001).
Successful fluorescence images were obtained in all ICG cases, without any adverse reactions. The fluorescence angiography evaluation altered the surgical plan in 23 patients (28.7%). In 22 patients the proximal colonic transection was modified, with a mean of 2.84 cm, all before the performance of any anastomosis. In one patient the transanal assessment showed insufficient anastomotic perfusion. This led to splenic flexure mobilization and tissue perfusion improved without further measures. AL occurred in 23 cases (11.3%) in the non-ICGA group vs. two (2.5%) cases in the ICGA group (p = 0.020). The rest of the complications are detailed in Table 3.
Four patients (5.1%) in the ICGA group presented abdominal/pelvic abscess formation. The first patient visited the outpatient clinic 15 days after index surgery explaining pelvic pain. An abdominal CT was performed showing a perianastomotic collection, without leakage of rectal contrast or pneumoperitoneum. In the second patient, the postoperative course was complicated by abdominal bleeding which required blood transfusion. Subsequently, on postoperative day 3, the patient developed fever, and a CT scan showed small presacral collection classified as hematoma, with no contrast extravasation. The patient was treated with antibiotics and could be discharged on postoperative day 8. The other two patients were those who presented an AL.
The median hospital stay was 6.0 (IQR 5.0–9.0) days in the non-ICG group vs. 4.0 (IQR 3.0–8.5) days in the ICGA group (p = 0.005). The mortality rate was 1% (n = 2), only in the non-ICGA group, being the cause of these two deaths an acute myocardial infarction in the immediate postoperative period, and a spontaneous esophageal perforation 3 months after the surgery.
From the whole sample size of patients (n = 284), univariate analysis identified three variables to be associated with the risk of developing AL (Table 4): transabdominal specimen extraction (OR 2.551; 95% CI 1.031–6.317, p = 0.043), diverting stoma (OR 0.265; 95% CI 0.114–0.612, p = 0.002), and ICGA (OR 0.204; 95 CI 0.047–0.888, p = 0.034). The defunctioning stoma has been shown not to prevent leakages, but to reduce the consequences of an anastomotic dehiscence [24]. Therefore, it was not included in the multivariate analysis, which showed that both ICGA and transabdominal specimen extraction remained statistically significant (Table 4).
Discussion
In this study, a cohort of patients operated by TaTME with ICGA was evaluated and compared with the largest unicentric cohort of patients treated with TaTME without ICGA. AL occurred in two cases (2.5%) in the ICGA group, while in the control group occurred in 23 cases (11.3%), (p = 0.020). The incidence of AL might have been reduced by a significant variation in the decision of where to transect the proximal colon.
The risk factors for colorectal AL have been well documented, and include preoperative variables (often not modifiable), intraoperative and postoperative. One of the essential intraoperative factors is that the edges to be anastomosed are well irrigated. ICGA is an easy-to-use, accessible and reproducible technology that allows real-time evaluation of the tissue perfusion, which visually helps the surgeon in deciding the proximal colonic transection line. This study not only demonstrated that ICGA is associated with a lower AL rate, but the absence of adverse effects validated its safety. Moreover, fluorescence images were successfully obtained in all cases. The impressive outcomes of ICGA have made that many surgeons use this technology for all colorectal anastomoses.
In the ICGA group, one of the two patients suffering an AL was a 49-year-old male, diagnosed with a rectal tumor located 9 cm from the anal verge, preoperatively staged as cT2N0M0. His BMI was 28 kg/m2, and he was a smoker and had dyslipidemia. A low IMA ligation was performed, and an end-to-end stapled anastomosis was constructed without diverting ileostomy nor splenic flexure mobilization. The use of ICGA had led to a change in the surgical plan, modifying the colon transection line by 3 cm. The other patient was a 70-year-old male, diagnosed with a rectal tumor located 4 cm from the anal verge, preoperatively staged as cT3N2bM0 and receiving chemoradiotherapy. His BMI was 26 kg/m2. An end-to-end manual anastomosis with a diverting stoma had been performed. The use of ICGA did not change the surgical plan.
Several groups have correlated ICG fluorescence angiography with a lower risk of leakage. Results from the PILAR II study reported an AL of 1.4% (n = 139), with no leakages in 11 patients (7.9%) who had a change in the surgical plan after ICGA [6]. We have confirmed this fact in a cohort of patients representative of the general community, obtaining an AL rate of 2.5%, while the rate obtained in the control group (11.3%) was similar to the one reported in the literature [25, 26]. Moreover, the observed reduction in the incidence of leakage in the ICGA group was consistent with the identification of ICGA as a protective factor in the multivariate analysis. This is of at least promising and supports the investment in this new technology.
The use of ICGA made us modify the proximal margin of resection in 27.5% patients. Kudszus et al. [10] reported a change in 14% of cases by laser fluorescence angiography. These findings were confirmed by Jafari et al. [27] using the Firefly system (Intuitive Surgical Inc), who reported a 19% change in the proximal resection margin compared to a 4.5% with visible light during low anterior robotic resections (study group: 16 vs. control group: 24), leading to decrease of AL by more than a half overall (60–65%). This suggests that conventional methods of evaluating bowel perfusion are not entirely reliable [10, 25, 28]. To date, methods such as hemorrhage, palpable pulse in the mesocolon and intestinal coloration have been used. However, these methods are based on the clinical judgment of the surgeon, which has been associated with an underestimation of the AL risk [28, 29]. Moreover, in colonic resections, the surgeon's judgment might be impaired by the deficient haptic and direct visual feedback of laparoscopic surgery. Besides, in our study, 14 of the 22 patients (63.63%) in whom the proximal resection margin was changed were older than 65, with an increased risk of atherosclerotic disease that might explain the relatively high rate of modification of the proximal colonic transection rate.
In a retrospective study, the role of ICGA was examined in patients undergoing anterior robotic resections [30]. The groups included 123 and 313 patients, and the average height of the anastomosis was 6.4 cm. An overall reduction of 4.6% in the AL rate (ICGA 0.8% vs. control: 5.4%, p = 0.03) was reported. In another retrospective study [31], Kin et al. included 173 patients and reported that 8 patients (5%) had a change in the proximal margin resection after using ICGA, one of which presented AL. The authors did not show differences in the AL rate between patients who were evaluated by ICGA (7.5%) and those who did not (6.4%).
Kawada et al. investigated the use of the PDE-neo ™ system (Hamamatsu Photonics K.K, Hamamatsu, Japan) in 68 patients undergoing laparoscopic left hemicolectomy for cancer [32]. The use of ICGA changed the proximal resection margin in 30.9% of the patients, with a change of more than 5 mm in the proximal resection margin in 18 patients, and a change of more han 50 mm in 3 patients. In this study, 3 patients with a change in the resection margin developed AL. Mizrahi et al. recently reported a study that included 60 patients: 30 patients in the ICGA group and 30 patients in the control group undergoing laparoscopic low anterior resection for rectal neoplasia with anastomoses < 5 cm from the anal verge [33]. All patients were diverted with a loop ileostomy. ICGA led to a change in surgical plan in four patients (13.3%), none of whom suffered an AL.
In general, TaTME is offered to patients with mid and low rectal tumors, resulting in lower anastomoses compared to other approaches [34]. The preparation of a distal anastomosis without tension is more feasible after splenic flexure mobilization and high ligation of the inferior mesenteric vessels. The role of IMA ligation in the risk of leakage remains controversial. Trencheva et al. found that a high ligation of the IMA entailed 3.8 times greater probability of AL [35], which might be explained by anatomical variations in the marginal artery of Drummond and in the vascular connection in the Griffith’s point [36]. However, in the ICGA group of our study, the change of proximal margin of resection in patients with high and low IMA ligation was of 25.7% and 35.7% respectively, suggesting that high ligation does not result in tissue hypoperfusion. This is consistent with the randomized trial of Fuiji et al. [37] and the HIGHLOW study [38].
The splenic flexure was mobilized in 34.3% of the patients, 70 cases in which ICGA was not used and 27 cases in patients in the ICGA group (34.3% vs. 34.2%, p = 0.983). From those, no AL was detected in patients in whom ICGA was performed. In one patient, splenic flexure mobilization was carried out after anastomosis performance due to poor perfusion in the ICGA. Therefore, ICG might also serve as an indicator of requiring additional maneuvers that relieve tension.
The increased transanal specimen exteriorization observed in the non-ICGA group can be explained by a decrease in the use of the transanal route after having observed some cases of mesorectal damaging over time. This, together with the theoretical risk of a proximal shearing of the marginal artery during transanal extraction, has made us to reserve this specimen extraction route for selected cases with wide pelvis and small tumors. Finally, a shorter length of hospital stay was observed in the ICGA group [4.0 (IQR 3.0–8.5) vs. 6.0 (IQR 5.0–9.0) days, p = 0.005]. This may be a consequence of the lower AL rate, as well as by the recent implementation of the Enhanced Recovery After Surgery (ERAS) protocol in our hospital .
Despite a similar defunctioning stoma rate, the decision to perform it was not protocolized but was at the discretion of the surgeon. Residual confounding might still be present, since unknown sublical leakages might have gone unnoticed. Another limitation of this study is the use of historic controls, which can increase the presence of biases due to the impossibility of blinding. However, between current patients and historical controls there have been no changes when it comes to extracting information and in the methodology to diagnose anastomotic leakages, minimizing the detection bias. Another limitation is its observational nature and the lack of sample size calculation. However, all consecutive patients were included, limiting the possibility of inclusion bias and providing a representative TaTME cohort with clinical applicability. The fact that the same surgical team has operated all patients and all the specimens evaluated by the same pathology team increased the internal validity, and external validity should be further addressed in randomized clinical trials. Also, our unit has been performing TaTME for more than 7 years, and the results obtained may not be applicable in centers at the beginning of their learning curve. That is why multicenter registries and controlled randomized studies are needed to facilitate a safe implementation in the routine clinical practice. Finally, the pathophysiology of AL is multifactorial, and factors with probable influence on its development such as gut microbiota, nutritional status, or the use of transanal drainage might also be taken into account for their confounding potential [39].
In conclusion, this comparative study showed that ICG fluorescence angiography is feasible, safe, and associated with a lower rate of AL in patients with rectal cancer treated by TaTME. ICGA modified the proximal colonic transection in more than one-quarter of patients. Moreover, it was found to be an independent protective factor for AL in the whole cohort of patients. Further research and the development of quantitative rather than qualitative fluorescence evaluation will clarify if the outcomes can continue to improve.
References
Alberts JCJ, Parvaiz A, Moran BJ (2003) Predicting risk and diminishing the consequences of anastomotic dehiscence following rectal resection. Colorectal Dis 5(5):478–482
Mäkelä JT, Kiviniemi H, Laitinen S (2003) Risk factors for anastomotic leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum 46(5):653–660
Sorensen LT, Jorgensen T, Kirkeby LT, Skovdal J, Vennits B, Wille-Jorgensen P (1999) Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg 86(7):927–931
Golub R, Golub RW, Cantu R, Stein HD (1997) A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 184(4):364–372
Park JS, Choi G-S, Kim SH, Kim HR, Kim NK, Lee KY, Kim BC, Bae BN, Son GM, Lee SI, Kang H (2013) Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision. Ann Surg 257(4):665–671
Jafari MD, Wexner SD, Martz JE, McLemore EC, Margolin DA, Sherwinter DA, Lee SW, Senagore AJ, Phelan MJ, Stamos MJ (2015) Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg 220(1):82–92
Pigazzi A, Luca F, Patriti A, Valvo M, Ceccarelli G, Casciola L, Biffi R, Garcia-Aguilar J, Baek JH (2010) Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol 17(6):1614–1620
Senagore A, Lane FR, Lee E, Wexner S, Dujovny N, Sklow B, Rider P, Bonello J, Bioabsorbable Staple Line Reinforcement Study Group (2014) Bioabsorbable staple line reinforcement in restorative proctectomy and anterior resection: a randomized study. Dis Colon Rectum 57(3):324–330
Kingham TP, Pachter HL (2009) Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 208(2):269–278
Kudszus S, Roesel C, Schachtrupp A, Höer JJ (2010) Intraoperative laser fluorescence angiography in colorectal surgery: a noninvasive analysis to reduce the rate of anastomotic leakage. Langenbeck’s Arch Surg 395(8):1025–1030
Kawada K, Hasegawa S, Hida K, Hirai K, Okoshi K, Nomura A, Kawamura J, Nagayama S, Sakai Y (2014) Risk factors for anastomotic leakage after laparoscopic low anterior resection with DST anastomosis. Surg Endosc 28(10):2988–2995
Boni L, David G, Dionigi G, Rausei S, Cassinotti E, Fingerhut A (2016) Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection. Surg Endosc 30(7):2736–2742
James DRC, Ris F, Yeung TM, Kraus R, Buchs NC, Mortensen NJ, Hompes RJ (2015) Fluorescence angiography in laparoscopic low rectal and anorectal anastomoses with pinpoint perfusion imaging a critical appraisal with specific focus on leak risk reduction. Colorectal Dis 3:16–21
Koh FH, Tan K-K (2016) Fluorescent angiography used to evaluate the perfusion status of anastomosis in laparoscopic anterior resection. Ann Surg Oncol 23(5):692
Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24(5):1205–1210
Wolthuis AM, Bislenghi G, Van Overstraeten ADB, D’Hoore A (2015) Transanal total mesorectal excision: Towards standardization of technique. World J Gastroenterol 21(44):12686–12695
Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, Liu H, Wang Z (2016) Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 16(1):380
Simillis C, Hompes R, Penna M, Rasheed S, Tekkis pp. (2016) A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis 18(1):19–36
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J et al (2017) Transanal Total Mesorectal Excision. Ann Surg 266(1):111–117
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP (2019) International TaTMERegistry Collaborative incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the International TaTME Registry. Ann Surg. 269(4):700–711
Deijen CL, Tsai A, Koedam TWA, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20(12):811–824
Arroyave MC, DeLacy FB, Lacy AM (2017) Transanal total mesorectal excision (TaTME) for rectal cancer: step by step description of the surgical technique for a two-teams approach. Eur J Surg Oncol 43(2):502–505
Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, Laurberg S, den Dulk M, van de Velde C, Büchler MW (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 147(3):339–351
McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC (2015) Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. British J Surgery 102(5):462–479
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, Heath RM, Brown JM, MRC CLASICC Trial Group (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet (London, England). 365(9472):1718–1726
Sauer R, Fietkau R, Wittekind C, Rödel C, Martus P, Hohenberger W, Tschmelitsch J, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R, German Rectal Cancer Group (2003) Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis. 5(5):406–415
Jafari MD, Lee KH, Halabi WJ, Mills SD, Carmichael JC, Stamos MJ, Pigazzi A (2013) The use of indocyanine green fluorescence to assess anastomotic perfusion during robotic assisted laparoscopic rectal surgery. Surg Endosc 27(8):3003–3008
Markus PM, Martell J, Leister I, Horstmann O, Brinker J, Becker H (2005) Predicting postoperative morbidity by clinical assessment. Br J Surg 92(1):101–106
Karliczek A, Harlaar NJ, Zeebregts CJ, Wiggers T, Baas PC, van Dam GM (2009) Surgeons lack predictive accuracy for anastomotic leakage in gastrointestinal surgery. Int J Colorectal Dis 24(5):569–576
Kim JC, Lee JL, Yoon YS, Alotaibi AM, Kim J (2016) Utility of indocyanine-green fluorescent imaging during robot-assisted sphincter-saving surgery on rectal cancer patients. Int J Med Robot 12(4):710–717
Kin C, Vo H, Welton L, Welton M (2015) Equivocal effect of intraoperative fluorescence angiography on colorectal anastomotic leaks. Dis Colon Rectum 58(6):582–587
Kawada K, Hasegawa S, Wada T, Takahashi R, Hisamori S, Hida K, Sakai Y (2017) Evaluation of intestinal perfusion by ICG fluorescence imaging in laparoscopic colorectal surgery with DST anastomosis. Surg Endosc. 31(3):1061–1069
Mizrahi I, Abu-Gazala M, Rickles AS, Fernandez LM, Petrucci A, Wolf J, Sands DR, Wexner SD (2018) Indocyanine green fluorescence angiography during low anterior resection for low rectal cancer: results of a comparative cohort study. Tech Coloproctol 22(7):535–540
Fernández-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Del Gobbo GD, DeLacy B, Balust J, Lacy AM (2015) Transanal total mesorectal excision in rectal cancer short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261(2):221–227
Trencheva K, Morrissey KP, Wells M, Mancuso CA, Lee SW, Sonoda T, Michelassi F, Charlson ME, Milsom JW (2013) Identifying important predictors for anastomotic leak after colon and rectal resection. Ann Surg 257(1):108–113
Meyers MA (1976) Griffiths’ point: critical anastomosis at the splenic flexure. Significance in ischemia of the colon. AJR Am J Roentgenol 126(1):77–94
Fujii S, Ishibe A, Ota M, Watanabe K, Watanabe J, Kunisaki C, Endo I (2018) Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer. BJS Open 2(4):195–202
Mari GM, Crippa J, Cocozza E, Berselli M, Livraghi L, Carzaniga P, Valenti F, Roscio F, Ferrari G, Mazzola M, Magistro C, Origi M, Forgione A, Zuliani W, Scandroglio I, Pugliese R, Costanzi ATM, Maggioni D (2018) Low ligation of inferior mesenteric artery in laparoscopic anterior resection for rectal cancer reduces genitourinary dysfunction: results from a randomized controlled trial (HIGHLOW Trial). Ann Surg. 296:1018–1024
Sciuto A, Merola G, De Palma GD, Sodo M, Pirozzi F, Bracale UM, Bracale U (2018) Predictive factors for anastomotic leakage after laparoscopic colorectal surgery. World J Gastroenterol 24(21):2247–2260. https://doi.org/10.3748/wjg.v24.i21.2247
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Antonio M. Lacy is a consultant for Medtronic, Conmed Corporation, Olympus Medical, Touchstone International Medical Science Co. Ltd., Applied Medical, and Johnson & Johnson. Drs. Otero-Piñeiro AM, de Lacy FB, Van Laarhoven JJ, Martín-Perez B, Valverde S, Bravo R has no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Otero-Piñeiro, A.M., de Lacy, F.B., Van Laarhoven, J.J. et al. The impact of fluorescence angiography on anastomotic leak rate following transanal total mesorectal excision for rectal cancer: a comparative study. Surg Endosc 35, 754–762 (2021). https://doi.org/10.1007/s00464-020-07442-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07442-6